ZMYM2

Chr 13AD

zinc finger MYM-type containing 2

Also known as: FIM, MYM, NECRC, RAMP, SCLL, ZNF198

The protein encoded by this gene is a zinc finger protein that may act as a transcription factor. The encoded protein may be part of a BHC histone deacetylase complex. Translocation of this gene with the fibroblast growth factor receptor-1 gene (FGFR1) results in a fusion gene, which may be a cause of stem cell leukemia lymphoma syndrome (SCLL). Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010]

OMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.331 OMIM phenotype
Clinical SummaryZMYM2
🧬
Gene-Disease Validity (ClinGen)
syndromic complex neurodevelopmental disorder · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.67) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
106 unique Pathogenic / Likely Pathogenic· 255 VUS of 430 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.33LOEUF
pLI 0.666
Z-score 6.06
OE 0.22 (0.140.33)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
3.01Z-score
OE missense 0.67 (0.620.73)
451 obs / 670.7 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.22 (0.140.33)
00.351.4
Missense OE?0.67 (0.620.73)
00.61.4
Synonymous OE?0.90
01.21.6
LoF obs/exp: 15 / 69.5Missense obs/exp: 451 / 670.7Syn Z: 1.17
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongZMYM2-related developmental disorderLOFAD

This gene — mechanism propensity

DN
0.3296th %ile
GOF
0.3094th %ile
LOF
0.67top 25%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 1 literature citation · 97% of P/LP variants are LoF · LOEUF 0.33

Literature Evidence

LOFThrough collaboration, we identified in total 14 different heterozygous loss-of-function mutations in ZMYM2 in 15 unrelated families.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 32891193

ClinVar Variant Classifications

430 submitted variants in ClinVar

Classification Summary

Pathogenic45
Likely Pathogenic61
VUS255
Likely Benign25
Benign8
Conflicting2
45
Pathogenic
61
Likely Pathogenic
255
VUS
25
Likely Benign
8
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
45
0
0
0
45
Likely Pathogenic
58
0
3
0
61
VUS
14
230
10
1
255
Likely Benign
0
9
2
14
25
Benign
0
1
2
5
8
Conflicting
2
Total1172401720396

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

44 pathogenic / likely-pathogenic (of 74) ClinVar copy-number / structural variants overlap ZMYM2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ZMYM2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →